ArticleInternational journal of environmental research and public health2018
Willingness to Participate in Vaccine-Related Clinical Trials among Older Adults.
Article in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Article
- Barriers and Opportunities to Include Underrepresented Population Groups in Vaccine Trials: Cross-Sectional, Observational, Online Survey Study From the VACCELERATE Research Network.JMIR public health and surveillance · 2026Observational
- A study on the prevalence and influencing factors of the willingness of healthy subjects to participate in clinical trials.Frontiers in public health · 2026Article
- Article
- Characteristics of Emergency Medicine Specimen Bank Participants Compared to the Overall Emergency Department Population.The western journal of emergency medicine · 2023Article
- Factors affecting willingness to participate in vaccine clinical trials in an underdeveloped country: perspective from Nepal.Human vaccines & immunotherapeutics · 2022Article
- A national platform for Covid-19 vaccine studies recruitment in France: Covireivac volunteer's characteristics.Human vaccines & immunotherapeutics · 2022Article
- Older Adults' Socio-Demographic Determinants of Health Related to Promoting Health and Getting Preventive Health Care in Southern United States: A Secondary Analysis of a Survey Project Dataset.Nursing reports (Pavia, Italy) · 2021Article
- What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.The Lancet. Infectious diseases · 2021Review
- Public Willingness to Pay for and Participate in Sanitation Infrastructure Improvement in Western China's Rural Areas.Frontiers in public health · 2021Article
- Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda.PloS one · 2021Article
- Health Communication and Decision Making about Vaccine Clinical Trials during a Pandemic.Journal of health communication · 2020Article
- Primary physicians' attitudes toward their patients receiving a proposal to participate in a vaccine trial.Human vaccines & immunotherapeutics · 2019Article
- Willingness to Participate and Associated Factors in a Zika Vaccine Trial in Indonesia: A Cross-Sectional Study.Viruses · 2018Article
- Characteristics, attitudes, and the odds for positive attitude toward clinical trial: A study on Indonesian COVID-19 vaccine trial participants.Perspectives in clinical researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study is to understand among a convenience sample of 400 adults aged 60 years of age or older (1) reasons for being willing or unwilling to participate in a vaccine clinical research study and (2) overall perceptions about vaccine clinical research. A cross-sectional study using a sample of older adults residing in the metro-Atlanta area and surrounding neighborhoods was conducted. The study questionnaire contained 37 questions, including questions about socio-demographics and perceptions about clinical trial processes. Statistical analysis was conducted using logistic regression. The adjusted modeling results indicated that sex, distance to research clinic, and being informed about the research findings played a role in the likelihood of an elderly person participating in a vaccine study. Males were more likely to participate in clinical trials as compared to females (OR: 2.486; CI: 1.042⁻5.934). Most participants were willing to travel up to 25 miles from the research clinic. Of the respondents, 45% were unlikely to participate if the results of the current trial are not shared. Improving access to clinical trials in terms of distance traveled and ensuring streamlined processes to inform participants about the results of the trial in the future would increase willingness to participate in vaccine clinical trials. The survey could serve as a useful tool for conducting vaccine studies and other clinical trials by understanding the barriers specific to the elderly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.